SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
PYOTT DAVID E I

(Last) (First) (Middle)
2525 DUPONT DRIVE

(Street)
IRVINE CA 92612

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ALLERGAN INC [ AGN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chairman, President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
10/04/2012
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/21/2012 G V 19,473 D (1) 165,000 D
Common Stock 09/21/2012 G V 19,473 A (1) 226,396 I By Living Trust (2)
Common Stock 10/04/2012 S 206,923 (3) D $93.7388 (4) 19,473 I By Living Trust (2)
Common Stock 10/04/2012 M 119,000 (3) A $30.125 138,473 I By Living Trust (2)
Common Stock 10/04/2012 M 90,623 (3) A $41.24 229,096 I By Living Trust (2)
Common Stock 10/04/2012 M 101,421 (3) A $41.24 330,517 I By Living Trust (2)
Common Stock 10/04/2012 S 101,421 (3) D $93.7132 (5) 229,096 I By Living Trust (2)
Common Stock 10/05/2012 M 307,956 (3) A $41.24 537,052 I By Living Trust (2)
Common Stock 10/05/2012 S 307,956 (3) D $93.724 (6) 229,096 I By Living Trust (2)
Common Stock 2,171.2877 I By 401(k) Trust (7)
Common Stock 2,884.9469 I By Esop Trust (8)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $30.125 10/04/2012 M 119,000 (9) 01/30/2013 Common Stock 119,000 $0 0 I By Living Trust
Employee Stock Option (Right to Buy) $41.24 10/04/2012 M 90,623 (10) 01/29/2014 Common Stock 90,623 $0 409,377 I By Living Trust
Employee Stock Option (Right to Buy) $41.24 10/04/2012 M 101,421 (10) 01/29/2014 Common Stock 101,421 $0 307,956 I By Living Trust
Employee Stock Option (Right to Buy) $41.24 10/05/2012 M 307,956 (10) 01/29/2014 Common Stock 307,956 $0 0 I By Living Trust
Explanation of Responses:
1. Transfer of 19,473 shares held directly by the reporting person to the David & Julianna Pyott Living Trust.
2. David and Julianna Pyott Living Trust dated June 14, 1999, in which the reporting person has a pecuniary interest and of which the reporting person and his spouse are each trustees.
3. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 20, 2012.
4. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $93.3950 to $93.9850, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
5. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $93.5400 to $93.9900, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
6. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $$93.4800 to $94.3600, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
7. Shares allocated to reporting person's SIP account as of reporting date.
8. Shares allocated to the reporting person's ESOP account as of reporting date.
9. The option becomes exercisable in four equal annual installments beginning January 31, 2004.
10. The option becomes exercisable in four equal annual installments beginning January 30, 2005.
/s/ Matthew J. Maletta, attorney-in-fact for David E.I. Pyott 10/05/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.